Kua Liu

机构：Nanjing Drum Tower Hospital

发表论文 12 篇 · 总被引 275 次 · h-index 7

代表论文

• Hypoxia signaling in cancer: Implications for therapeutic interventions (2023 · MedComm · 被引 114)
• Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy (2024 · Cell Reports Medicine · 被引 63)
• The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies (2023 · Cell & Bioscience · 被引 41)
• SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy (2025 · Cell Death and Differentiation · 被引 19)
• MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway (2024 · Cancer Biology & Therapy · 被引 13)
• Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway (2023 · Heliyon · 被引 11)